Literature DB >> 25546380

Cerebral white matter lesions in patients with cirrhosis - causative for hepatic encephalopathy or bystanders?

Henning Pflugrad1,2, Paul Bronzlik3, Peter Raab3, Anita B Tryc1,2, Annemarie Goldbecker1,2, Hannelore Barg-Hock4, Christian P Strassburg5,6, Xiao-Qi Ding3, Heinrich Lanfermann3, Karin Weissenborn1,2.   

Abstract

BACKGROUND & AIMS: Focal white matter lesions mimicking microvascular lesions were connected to the development of hepatic encephalopathy (HE) in patients with cirrhosis. This study aims to assess the relationship between cerebrovascular risk factors and the prevalence and extent of these lesions in patients with cirrhosis, as well as their impact upon cognitive function.
METHODS: 55 cirrhotic patients underwent neurological examination, psychometric testing and magnetic resonance imaging. T2-weighted images were reviewed for white matter lesions by a neuroradiologist and a neurologist, independently. Patients were allocated into three groups: (i) no or <5, (ii) 6-15 and (iii) more than 15 lesions. Allocation was confirmed by a senior neuroradiologist blinded for the clinical data. The patient groups were compared concerning age, underlying liver disease, mortality, MELD Score, history of HE, treatment for HE, cerebrovascular risk factors and psychometric test results. Regression analysis was performed to identify risk factors for the presence and extent of white matter lesions.
RESULTS: Patient groups 2 and 3 were older and showed worse results in the psychometric tests than group 1 (P < 0.05). Correlation analyses showed a significant relationship between the number of white matter lesions and the grade of HE (P < 0.001) and cognitive function (P < 0.05), but no interrelationship between the lesions and cerebrovascular risk factors or other factors tested.
CONCLUSIONS: Focal white matter lesions in patients with cirrhosis do not represent cerebrovascular small-vessel disease but are related to the pathology of HE. Further studies are needed to clarify the mechanisms behind in detail.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  cerebrovascular risk factors; cognitive function; psychometric hepatic encephalopathy score (PHES); subcortical arteriosclerotic encephalopathy; white matter lesions

Mesh:

Year:  2015        PMID: 25546380     DOI: 10.1111/liv.12771

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  4 in total

1.  Clinical impact of preoperative brain MR angiography and MR imaging in candidates for liver transplantation: a propensity score-matching study in a single institution.

Authors:  Mi Sun Chung; Ho Sung Kim; Young-Suk Lim; Sang-Beom Jeon; Seon-Ok Kim; Hwa Jung Kim; Shin Hwang; Seung Chai Jung; Choong Gon Choi; Sang Joon Kim
Journal:  Eur Radiol       Date:  2017-01-20       Impact factor: 5.315

2.  Peroxisome proliferator-activated receptor-γ doesn't modify altered electrophysiological properties of the CA1 pyramidal neurons in a rat model of hepatic cirrhosis.

Authors:  Mahshid Tahamtan; Iraj Aghaei; Mohammad Shabani; Abbas Nazari; Vahid Pooladvand; Moazamehosadat Razavinasab
Journal:  Metab Brain Dis       Date:  2022-08-09       Impact factor: 3.655

3.  The interaction between brain and liver regulates lipid metabolism in the TBI pathology.

Authors:  Victoria Palafox-Sánchez; Zhe Ying; Luiz Fernando Freire Royes; Fernando Gomez-Pinilla
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2021-01-12       Impact factor: 5.187

4.  The Presence of White Matter Lesions Is Associated With the Fibrosis Severity of Nonalcoholic Fatty Liver Disease.

Authors:  Salvatore Petta; Antonino Tuttolomondo; Cesare Gagliardo; Rita Zafonte; Giuseppe Brancatelli; Daniela Cabibi; Calogero Cammà; Vito Di Marco; Luigi Galvano; Giuseppe La Tona; Anna Licata; Franco Magliozzo; Carlo Maida; Giulio Marchesini; Giovanni Merlino; Massimo Midiri; Gaspare Parrinello; Daniele Torres; Antonio Pinto; Antonio Craxì
Journal:  Medicine (Baltimore)       Date:  2016-04       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.